Automate Your Wheel Strategy on CVS
With Tiblio's Option Bot, you can configure your own wheel strategy including CVS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CVS
- Rev/Share 316.5882
- Book/Share 59.3559
- PB 1.3002
- Debt/Equity 1.2444
- CurrentRatio 0.8424
- ROIC 0.0212
- MktCap 97960170000.0
- FreeCF/Share 6.1472
- PFCF 12.5477
- PE 55.3111
- Debt/Assets 0.3585
- DivYield 0.0345
- ROE 0.0234
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | CVS | Goldman | -- | Buy | -- | $91 | Oct. 14, 2025 |
| Upgrade | CVS | UBS | Neutral | Buy | -- | $79 | Aug. 18, 2025 |
| Upgrade | CVS | Robert W. Baird | Neutral | Outperform | -- | $82 | Aug. 14, 2025 |
| Upgrade | CVS | Leerink Partners | Market Perform | Outperform | $55 | $75 | Feb. 13, 2025 |
| Upgrade | CVS | Cantor Fitzgerald | Neutral | Overweight | -- | -- | Feb. 12, 2025 |
| Upgrade | CVS | Edward Jones | Hold | Buy | -- | -- | Jan. 30, 2025 |
| Upgrade | CVS | Deutsche Bank | Hold | Buy | -- | $66 | Dec. 3, 2024 |
| Upgrade | CVS | Barclays | Equal Weight | Overweight | $63 | $82 | Oct. 10, 2024 |
| Upgrade | CVS | TD Cowen | Hold | Buy | $59 | $85 | Oct. 4, 2024 |
News
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
Published: February 18, 2026 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Read More
Here's Why CVS Health (CVS) is a Strong Value Stock
Published: February 17, 2026 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Here's Why CVS Health (CVS) is a Strong Growth Stock
Published: February 16, 2026 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
CVS Health: Why Margin Compression In Aetna Limits The Upside For 2026
Published: February 10, 2026 by: Seeking Alpha
Sentiment: Positive
CVS Health Corporation is rated a Hold, reflecting balanced risk and income potential amid persistent Medicare Advantage cost pressures. Q4 2025 saw record revenue, but rising medical costs in Aetna drove a $1B cut to FY 2026 cash flow guidance, now at $9B. CVS Health's valuation is highly sensitive to margin changes, with exposure to Medicare Advantage limiting upside barring significant CMS rate increases.
Read More
CVS Beats on Q4 Earnings and Revenues but Shares Slide in Pre-Market
Published: February 10, 2026 by: Zacks Investment Research
Sentiment: Positive
CVS beats Q4 earnings and revenue estimates, but higher costs squeeze margins. Shares slip pre-market despite upbeat 2026 EPS guidance.
Read More
CVS Health Corporation (CVS) Q4 2025 Earnings Call Transcript
Published: February 10, 2026 by: Seeking Alpha
Sentiment: Neutral
CVS Health Corporation (CVS) Q4 2025 Earnings Call Transcript
Read More
CVS Health (CVS) Reports Q4 Earnings: What Key Metrics Have to Say
Published: February 10, 2026 by: Zacks Investment Research
Sentiment: Positive
The headline numbers for CVS Health (CVS) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read More
CVS Health posts strong Q4 revenue, raises full-year guidance
Published: February 10, 2026 by: Proactive Investors
Sentiment: Positive
CVS Health Corp (NYSE:CVS) on Tuesday reported stronger-than-expected fourth-quarter revenue and adjusted earnings, driven by growth across its pharmacy, health services, and insurance businesses. The US pharmacy chain and health insurer said fourth-quarter revenue rose 8.2% to $105.7 billion, topping analysts' expectations of $103.6 billion.
Read More
CVS Health (CVS) Tops Q4 Earnings and Revenue Estimates
Published: February 10, 2026 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $1.19 per share a year ago.
Read More
The CVS Earnings Bombshell That Has Investors Scrambling Right Now
Published: February 10, 2026 by: 24/7 Wall Street
Sentiment: Positive
CVS Health (NYSE: CVS) delivered a solid revenue beat in Q4 2025, though adjusted earnings declined year-over-year despite exceeding Wall Street expectations.
Read More
What Analyst Projections for Key Metrics Reveal About CVS Health (CVS) Q4 Earnings
Published: February 05, 2026 by: Zacks Investment Research
Sentiment: Positive
Besides Wall Street's top-and-bottom-line estimates for CVS Health (CVS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.
Read More
Will Pharmacy and Consumer Wellness Segment Lead CVS' Q4 Earnings?
Published: February 04, 2026 by: Zacks Investment Research
Sentiment: Neutral
CVS Health may report higher Q4 revenues, led by prescription growth and expanded pharmacy operations.
Read More
CVS Health: Exploit The Sector Panic Ahead Of Earnings
Published: February 03, 2026 by: Seeking Alpha
Sentiment: Negative
CVS Health remains well-positioned despite a sector-wide selloff after disappointing Medicare rate increases and UnitedHealth's outlook. CVS's early restructuring, cost cuts, and reduced Medicare exposure have prepared it better than peers for current industry headwinds. At 10–11x forward earnings, CVS trades at a discount to peers, with potential for multiple expansion if execution continues.
Read More
CVS Health (CVS) Expected to Beat Earnings Estimates: Should You Buy?
Published: February 03, 2026 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Why CVS Health (CVS) is a Top Value Stock for the Long-Term
Published: January 30, 2026 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
Published: January 26, 2026 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read More
UNH Stock vs. CVS
Published: January 15, 2026 by: Forbes
Sentiment: Negative
UnitedHealth‘s stock has significantly lagged behind competitors like CVS and Centene over the previous year. A detailed examination indicates strong profitability, with an LTM Operating Margin of 6%, combined with a moderate valuation, as reflected by a PE of 17.2 in contrast to CVS's 218.3.
Read More
CVS Health (CVS) is a Top-Ranked Value Stock: Should You Buy?
Published: January 13, 2026 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
Published: January 13, 2026 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Read More
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
Published: January 12, 2026 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term
Published: January 12, 2026 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
CVS Health to hold fourth quarter and full year 2025 earnings conference call
Published: January 09, 2026 by: PRNewsWire
Sentiment: Neutral
WOONSOCKET, R.I., Jan. 9, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, February 11th, 2026, at 8:00 a.m.
Read More
Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock
Published: December 31, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Read More
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
Published: December 30, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Read More
Health Insurers Now Get a Pulse: 3 Stocks to Jump in 2026
Published: December 17, 2025 by: Zacks Investment Research
Sentiment: Neutral
Health insurers are regaining pricing control and margin visibility, putting UnitedHealth, CVS Health and Centene back in focus as managed care regains its pulse.
Read More
Is Trending Stock CVS Health Corporation (CVS) a Buy Now?
Published: December 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
Codoxo's Oversubscribed Series C Led by CVS Health Ventures to Revolutionize Payment Integrity for America's Largest Health Plans
Published: December 17, 2025 by: Business Wire
Sentiment: Neutral
DULUTH, Ga.--(BUSINESS WIRE)--Codoxo, the leading provider of AI and generative AI-powered healthcare payment integrity solutions, raised $35M in Series C funding, led by CVS Health Ventures. Echo Health Ventures joins the round as a new investor, with continued investment from existing investors including Sands Capital, 111 West Capital, Brewer Lane Ventures, Wipro Ventures, 450 Ventures (venture arm of Blue Cross and Blue Shield of Alabama) and QED Investors. This milestone brings Codoxo's to.
Read More
CVS Stock Gains From Offering MMR Vaccine to South Carolina Residents
Published: December 15, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health shares jump after the company begins offering MMR vaccines across South Carolina pharmacies and clinics post a measles outbreak.
Read More
Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term
Published: December 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
CVS Health offering measles vaccine to South Carolina residents amid the state's current outbreak
Published: December 11, 2025 by: PRNewsWire
Sentiment: Neutral
Unvaccinated residents can receive a measles vaccine at select CVS Pharmacy and MinuteClinic locations across the state WOONSOCKET, R.I. , Dec. 11, 2025 /PRNewswire/ -- As South Carolina public health officials work to stop the spread of measles following the current outbreak in the state, CVS Health® (NYSE:CVS) is offering the measles-mumps-rubella (MMR) vaccine to residents.
Read More
About CVS Health Corporation (CVS)
- IPO Date 1996-11-20
- Website https://www.cvshealth.com
- Industry Medical - Healthcare Plans
- CEO J. David Joyner
- Employees 219000